Migraine Trial, Recruiting NCT06229834 Sponsor: Brigham and Women's Hospital Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT06229834
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You have been diagnosed with migraine (with or without aura) that is not classified as "chronic migraine" by your doctor
  • You have had migraines for at least one year
  • You have had between 4 and 13 migraine days per month during an initial tracking period
  • You completed at least 26 out of 28 days of a headache diary during the tracking period
  • If you take any medications, your dose has been stable for at least 2 months before joining the study
  • You are willing and able to take part in all parts of the study and be randomly placed into one of two groups
  • You speak and understand English fluently
  • You have reliable access to and can use a smartphone, computer, or tablet
  • You have a working email address or are willing to create one for the study

Who may not be able to join:

  • You are not a Veteran (for the VA Medical Center site only)
  • You received Botox injections for headache or neck pain in the past 4 months
  • You received chiropractic care for any reason in the past 3 months
  • You have had behavioral therapy (such as cognitive behavioral therapy, mindfulness, relaxation techniques, or hypnosis) in the past 3 months
  • You have used a headache device or nerve-stimulating device for migraine prevention in the past 2 months, or took part in a study using experimental treatments in the past 90 days
  • You have been diagnosed with "medication overuse headache" by the study doctor at your screening visit
  • You had a traumatic brain injury within the past year, or your migraines have been getting worse (confirm with trial site)
  • You had a head or neck injury in the past year that caused nerve or muscle problems requiring treatment
  • You have any medical, neurological, or mental health condition that the study doctor believes could make it hard to safely participate (confirm with trial site)
  • You have been hospitalized for a psychiatric/mental health reason in the past 6 months
  • You are currently receiving hospice or palliative care
  • You have a history of a tear in one of the major arteries in your neck (carotid or vertebral artery dissection)
  • A doctor has detected an abnormal sound in your neck arteries (carotid bruits)
  • You have certain spine or bone conditions that would make spinal manipulation or mobilization unsafe, including but not limited to:
    • Unstable or overly flexible spine joints
    • Conditions causing general joint looseness, such as Marfan syndrome, Ehlers-Danlos syndrome, or Osteogenesis imperfecta
    • Cancer of the spine or spinal cord
    • A slipped disc with worsening nerve symptoms
    • Blood pooling near the spine
    • Inflammatory spine conditions such as rheumatoid arthritis
    • Broken bones or dislocations in the spine
    • Bone tissue death in an area that might be treated
    • Bone-weakening conditions of the spine, such as tumors, infection, or osteoporosis
    • Poor blood flow to the back of the brain (vertebrobasilar insufficiency)
    • An aneurysm (bulging blood vessel) near an area that might be treated
  • You have a history of stroke
  • You take blood-thinning medication or have a blood disorder that causes significant bleeding
  • You have had previous neck spine surgery, or you have a birth defect affecting the stability or nerve function of your cervical (neck) spine
  • You currently have, or have been treated for, an alcohol or substance use disorder in the past 6 months
  • You have been on hormone replacement therapy for less than 6 months, or your dose has not been stable (confirm with trial site)
  • You have significant memory or thinking difficulties that would affect your ability to participate
  • You are currently pregnant or plan to become pregnant within the next 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617-278-0835

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 March 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment feasibility (average number of participants per month); Retention feasibility (proportion of participants not lost to follow-up); Intervention adherence feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov